ASBP
Aspire Biopharma
ASBP
ASBP
19 hedge funds and large institutions have $18.1M invested in Aspire Biopharma in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 21 → 19 (-2)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.3M | |
| 2 | +$628K | |
| 3 | +$559K | |
| 4 |
QL
Quarry LP
New York
|
+$387K |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$351K |
Top Sellers
| 1 | -$1.45M | |
| 2 | -$1.11M | |
| 3 | -$689K | |
| 4 |
SOA
Sea Otter Advisors
Miami,
Florida
|
-$12.2K |
| 5 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
-$3.58K |